A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
Robert Bodén,1,2 Gunnar Edman,3,4 Johan Reutfors,2 Claes-Göran Östenson,3 Urban Ösby3,4 1Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden; 2Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Insti...
Guardado en:
Autores principales: | Bodén R, Edman G, Reutfors J, Östenson CG, Ösby U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/409632f52b8649e08e6a97a2ede8cf30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar Ö, et al.
Publicado: (2012) -
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Johan Lökk
Publicado: (2010) -
Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings
por: Antoni Sicras-Mainar, et al.
Publicado: (2008) -
The classification of chronic daily headache in French children and adolescents: A comparison between the second edition of the International Classification of Headache Disorders and Silberstein-Lipton criteria
por: Jean-Christophe Cuvellier, et al.
Publicado: (2008) -
Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program
por: Britt-Marie Stålnacke, et al.
Publicado: (2010)